Tuberculosis and latent tuberculous infection screening of migrants in Europe: Comparative analysis of policies, surveillance systems and results

International Journal of Tuberculosis and Lung Disease

Volumn 21, Issue 8, 2017, Pages 840-851

  Kunst, H ^a,b   Burman, M ^a,b   Arnesen, T M ^c   Fiebig, L ^d   Hergens, M P ^e   Kalkouni, O ^f   Klinkenberg, E ^g,h   Orcau, A ^i,j   Soini, H ^k   Sotgiu, G ^l   Zenner, D ^m,n   De Vries, G ^g,o  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d ROBERT KOCH INSTITUTE   (Germany)

^e KAROLINSKA INSTITUTE   (Sweden)

^f Hellenic Center for Disease Control and Prevention   (Greece)

^g KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

ⁱ AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^j CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^k NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^l UNIVERSITY OF SASSARI   (Italy)

^m PUBLIC HEALTH ENGLAND   (United Kingdom)

ⁿ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^o NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

more..

Author keywords

Europe; Migrant; Screening; Tuberculosis

Indexed keywords

COMPARATIVE STUDY; DISEASE SURVEILLANCE; EUROPE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; LATENT TUBERCULOSIS; MASS SCREENING; MEDICAL INFORMATION; MIGRANT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STANDARDIZATION; SYSTEMATIC REVIEW; TUBERCULOSIS; INTERNATIONAL COOPERATION; MIGRATION; PROCEDURES; STATISTICS AND NUMERICAL DATA;

EUROPE; HEALTH POLICY; HUMANS; INTERNATIONALITY; LATENT TUBERCULOSIS; MASS SCREENING; POPULATION SURVEILLANCE; TRANSIENTS AND MIGRANTS; TUBERCULOSIS;

EID: 85018905507     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.17.0036     Document Type: Review

References (62)

1. World Health Organization. Systematic screening for active tuberculosis: principles and recommendations. WHO/HTM/TB/2013.04. Geneva, Switzerland: WHO, 2013.
2. Lönnroth K, Mor Z, Erkens C, et al. Tuberculosis in migrants in low-incidence countries: Epidemiology and intervention entry points. Int J Tuberc Lung Dis 2017; 21: 624-636.
3. Lönnroth K, Shah N S, Lange C. State-of-The-Art series on tuberculosis and migration. [Editorial] Int J Tuberc Lung Dis 2016; 20: 1280-1281.
4. Ricks P M, Cain K P, Oeltmann J E, Kammerer J S, Moonan P K. Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the US, 2005-2009. Plos One 2011; 6: E27405.
5. Lönnroth K, Raviglione M. The WHO's new End TB Strategy in the post-2015 era of the Sustainable Development Goals. Trans R Soc Trop Med Hyg 2016; 110: 148-150.
6. Uplekar M, Weil D, Lönnroth K, et al. WHO's new end TB strategy. Lancet 2015; 385: 1799-1801.
7. Lönnroth K, Migliori G B, Abubakar I, et al. Towards tuberculosis elimination: An action framework for lowincidence countries. Eur Respir J 2015; 45: 928-952.
8. Getahun H, Matteelli A, Abubakar I, et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J 2015; 46: 1563-1576.
9. Houben R M, Dodd P J. The global burden of latent tuberculosis infection: A re-estimation using mathematical modelling. Plos Med 2016; 13: E1002152.
10. Rieder H L, Zellweger J P, Raviglione MC, Keizer S T, Migliori G B. Tuberculosis control in Europe and international migration. Eur Respir J 1994; 7: 1545-1553.
11. International Organisation for Migration. Global migration factsheet 2016. Geneva, Switzerland: IOM, 2016. https://publications.iom.int/system/files/global-migration-Trends-2015-factsheet.pdf. Accessed June 2017.
12. World Health Organization: Interregional workshop for tuberculosis control and care among refugees and migrant populations. Geneva, Switzerland: WHO, 2016. http://www.euro.who.int/en/health-Topics/communicable-diseases/tuberculosis/publications/2016/interregional-workshop-fortuberculosis-control-And-care-Among-refugees-And-migrantpopulations-2016. Accessed May 2017.
13. E-detect TB: A research consortium for the early detection and integrated management of tuberculosis in Europe 2016. London, UK: University College London, 2016. https://edetecttb.eu/. Accessed May 2017.
14. Klinkenberg E, Manissero D, Semenza J C, Verver S. Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations. Eur Respir J 2009; 34: 1180-1189.
15. Coker R J, Bell A, Pitman R, Hayward A, Watson J. Screening programmes for tuberculosis in new entrants across Europe. Int J Tuberc Lung Dis 2004; 8: 1022-1026.
16. Coker R, Bell A, Pitman R, Zellweger JP, Heldal E, Hayward A, et al. Tuberculosis screening in migrants in selected European countries shows wide disparities. Eur Respir J 2006; 27: 801- 807.
17. Alvarez G G, Gushulak B, Abu Rumman K, et al. A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates. BMC Infect Dis 2011; 11: 3.
18. Dara M, Solovic I, Sotgiu G, et al. Tuberculosis care among refugees arriving in Europe: A ERS/WHOEurope Region survey of current practices. Eur Respir J 2016; 48: 808-817.
19. Akkerman OW, Schölvinck E H, Wolters B, Aartsma Y, van der Werf T S, van Hest R. Implementing tuberculosis entry screening for asylum seekers: The Groningen experience. Eur Respir J 2016; 48: 261-264.
20. Alcaide Megias J, Altet-Gòmez M N, de Souza-Galvao M L, Jimènez-Fuentes MA, Mila Augè C, Solsona Peirò J. [Active tuberculosis case finding among immigrants in Barcelona]. Arch Bronconeumol 2004; 40: 453-458. [Spanish].
21. Arrazola de Onate W, Weber L, Janssens K, Wanlin M, Forier A, Schol S, et al. Tuberculosis screening yield of asylum seekers in Europe. Eur Respir J 2016; 48: 1253-1254.
22. Aldridge R W, Zenner D, White P J. Prevalence of and risk factors for active tuberculosis in migrants screened before entry to the UK: A population-based cross-sectional study. Lancet Infect Dis 2016; 16: 962-970.
23. Crepet A, Repetto E, Al Rousan A, et al. Lessons learnt from TB screening in closed immigration centres in Italy. Int Health 2016; 8: 324-329.
24. de Vries G, Gerritsen R F, van Burg J L, Erkens C G M, et al. [Tuberculosis among asylum-seekers in the Netherlands: A descriptive study among the two largest groups of asylumseekers]. Ned Tijdschr Geneeskd 2015; 160: D51. [Dutch].
25. de Vries G, van Rest J, Meijer W, Wolters B, van Hest R. Low yield of screening asylum seekers from countries with a tuberculosis incidence of, 50 per 100 000 population. Eur Respir J 2016; 47: 1870-1872.
26. Diel R, Rüsch-Gerdes S, Niemann S. Molecular epidemiology of tuberculosis among immigrants in Hamburg, Germany. J Clin Microbiol 2004; 42: 2952-2960.
27. Erkens C, Slump E, Kamphorst M, et al. Coverage and yield of entry and follow-up screening for tuberculosis among new immigrants. Eur Respir J 2008; 32: 153-161.
28. Farah M G, Meyer H E, Selmer R, Heldal E, Bjune G. Longterm risk of tuberculosis among immigrants in Norway. Int J Epidemiol 2005; 34: 1005-1011.
29. Harling R, Pearce M, Chandrakumar M, Mueller K, Hayward A. Tuberculosis screening of asylum seekers: 1 years' experience at the Dover Induction Centres. Public Health 2007; 121: 822- 827.
30. Harstad I, Jacobsen G W, Heldal E, et al. The role of entry screening in case finding of tuberculosis among asylum seekers in Norway. BMC Public Health 2010; 10: 670.
31. Jimènez-Fuentes M A, Augè C M, Gòmez M N A, et al. Screening for active tuberculosis in high-risk groups. Int J Tuberc Lung Dis 2014; 18: 1459-1465.
32. Magkanas E, Drakonaki E E, Voloudaki A, Nerantzoulakis I, Gourtsoyiannis N. Chest radiography and tuberculosis casefinding in asymptomatic native and immigrant populations in Greece. Int J Tuberc Lung Dis 2005; 9: 865-869.
33. Mathez C, Bangala Y, Bady P, Zellweger J P. Active screening for pulmonary tuberculosis among immigrants by chest x-ray at the Swiss border. Swiss Med Wkly 2007; 137: 649-654.
34. Meier V, Artelt T, Cierpiol S, Gossner J, Scheithauer S. Tuberculosis in newly arrived asylum seekers: A prospective 12 month surveillance study at Friedland, Germany. Int J Hyg Environ Health 2016; 219: 811-815.
35. Monney M, Zellweger J-P. Active and passive screening for tuberculosis in Vaud Canton, Switzerland. Swiss Med Wkly 2005; 135: 469-474.
36. Pace-Asciak A, Mamo J, Calleja N. Tuberculosis among undocumented boat migrants to Malta: implications for amigrant tuberculosis policy. Int J Tuberc Lung Dis 2013; 17: 1065-1070.
37. Pacifici L E, Riccardo F, Russo G. Screening for tuberculosis among asylum seekers: Experience from an immigration centre in Central Italy and literature review. Giornale Ital Med Trop 2010; 15: 21-27.
38. Sanè Schepisi M, Gualano G, Fellus C, et al. Tuberculosis case finding based on symptom screening among immigrants, refugees and asylum seekers in Rome. BMC Public Health 2013; 13: 872.
39. Sanè Schepisi M, Gualano G, Piselli P, et al. Active tuberculosis case finding interventions among immigrants, refugees and asylum seekers in Italy. Infect Dis Rep 2016; 8: 1-7.
40. Schneeberger Geisler S, Helbling P, Zellweger J P, Altpeter E S. Screening for tuberculosis in asylum seekers: comparison of chest radiography with an interview-based system. Int J Tuberc Lung Dis 2010; 14: 1388-1394.
41. Severi E, Maguire H, Ihekweazu C, Bickler G, Abubakar I. Outcomes analysis of new entrant screening for active tuberculosis in Heathrow and Gatwick airports, United Kingdom 2009/2010. BMC Infect Dis 2016; 16: 178.
42. Alonso Moreno F J, Garcia Bajo M C, Lougedo Calderòn M J, et al. [Prevalence of tuberculosis infection among immigrants in the Toledo Health District, Spain.] Rev Esp Salud Publica 2004; 78: 593-600. [Spanish].
43. Winje B A, Oftung F, Korsvold G E, et al. Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONwTB Gold with tuberculin skin test. BMC Infect Dis 2008; 8: 65.
44. Baussano I, Mercadante S, Pareek M, Lalvani A, Bugiani M. High rates of Mycobacterium tuberculosis among socially marginalized immigrants in low-incidence area, 1991-2010, Italy. Emerg Infect Dis 2013; 19: 1437-1445.
45. Bodenmann P, Vaucher P, Wolff H, et al. Screening for latent tuberculosis infection among undocumented immigrants in Swiss healthcare centres; a descriptive exploratory study. BMC Infect Dis 2009; 9: 677-678.
46. Bran C, Gòmezi Prat J, Caylá J A, Garcia de Olalla P. Factors associated with latent tuberculous infection in immigrants less than 35 years old. Enferm Infecc Microbiol Clin 2006; 24: 322- 325. [Spanish].
47. Bua A, Cubeddu M, Piras D, Delogu R, Zanetti S, Molicotti P. Tuberculosis screening among asylum seekers in Sardinia. J Public Health (Oxf) 2016; 38: 760-764.
48. Carvalho A C C, Pezzoli M C, El-Hamad I, et al. QuantiFERON-TB Gold test in the identification of latent tuberculosis infection in immigrants. J Infect 2007; 55: 164- 168.
49. Carvalho ACC, Saleri N, El-Hamad I, et al. Completion of screening for latent tuberculosis infection among immigrants. Epidemiol Infect 2005; 133: 179-185.
50. Hardy A B, Varma R, Collyns T, Moffitt S J, Mullarkey C, Watson J P. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: The Quanti FERONTB Gold IGRA alone is more cost-effective for immigrants from high burden countries. Thorax 2010; 65: 178-180.
51. Mulder C, Mulleners B, Borgdorff M W, van Leth F. Predictive value of the tuberculin skin test among newly arriving immigrants. Plos One 2013; 8: E60130-e60138.
52. Mulder C, van Deutekom H, Huisman E M, et al. Role of the Quanti FERONw-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection. Eur Respir J 2012; 40: 1443-1449.
53. Olivan-Gonzalvo G. [Prevalence of hepatitis B, hepatitis C, HIV and latent tuberculosis infection and syphilis in a population of immigrant children at high social risk]. Enferm Infecc Microbiol Clin 2004; 22: 250. [Spanish].
54. Orlando G, Merli S, Cordier L, et al. Interferon-c releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants. Infection 2010; 38: 195-204.
55. Pareek M, Watson J P, Ormerod L P, et al. Screening of immigrants in the UK for imported latent tuberculosis: A multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis 2011; 11: 435-444.
56. Ramos J M, Pastor C, Masia M M, Cascales E, Royo G, Gutièrrez-Rodero F. [Health in the immigrant population: prevalence of latent tuberculosis, hepatitis B, hepatitis C, human immunodeficiency virus and syphilis infection]. Enferm Infecc Microbiol Cl?n 2003; 21: 540-542. [Spanish].
57. Saracino A, Scotto G, Fornabaio C. Quanti FERONw-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy. New Microbiol 2009; 32: 369- 376.
58. Sarivalasis A, Bodenmann P, Langenskiold E, Lutchmaya F, Daher O, Zellweger J P. High rate of completion of preventive therapy for latent tuberculosis infection among asylum seekers in a Swiss Canton. Swiss Med Wkly 2013; 143: W13860.
59. Serre Delcor N, Maruri T, Arandes A S, et al. Infectious diseases in Sub-Saharan immigrants to Spain. Am J Trop Med Hyg 2016; 94: 750-756.
60. Bocanegra C, Salvador F, Sulleiro E, Sánchez-Montalvá A, Pahissa A, Molina I. Screening for imported diseases in an immigrant population: Experience from a teaching hospital in Barcelona, Spain. Am J Trop Med Hyg 2014; 91: 1277-1281.
61. Hladun O, Grau A, Esteban E, Jansá J M. Results from screening immigrants of low-income countries: data from a public primary health care. J Travel Med 2014; 21: 92-98.
62. Zenner D, Mattelli A. Effectiveness and cost-effectiveness of screening migrants for active and latent TB: A narrative review of the evidence. Int J Tuberc Lung Dis 2017 [In press].